PIER LUIGI ZINZANI

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (3)

Lisa Argnani

Associate Professor

University of Bologna

ITALY

View details

Claudio Agostinelli

Associate Professor of Pathology

University of Bologna

ITALY

View details

Ewa Lech-Maranda

Institute of Hematology and Transfusion Medicine

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PIER LUIGI ZINZANI

Research Interests

Explore related searches

Contact this professor

Articles (10)

Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact. <i>Cancers</i> 2024, <i>16</i>, 4210

Different definitions in intention-to-treat analysis for chimeric antigen receptor T-cell therapy depend on research scope

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma

A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection

Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN Study

Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review

Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed/refractory marginal zone lymphoma

A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas

Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact

Collaborators (3)

Lisa Argnani

Claudio Agostinelli

Ewa Lech-Maranda

Make your next move.